model Clinical Trials Agreement (mCTA) mCTA adoption and implementation update Between September 26 and October 25, 2017, the CCTCC and members of the...
BC AHSN to integrate clinical research support function under Clinical Trials BC
HealthCareCAN welcomes Paul-Émile Cloutier as new President and CEO
The Canadian Clinical Trials Coordinating Centre – A Unique Partnership for Promoting Canada as a Destination for Clinical Trials: Part II
The Canadian Clinical Trials Coordinating Centre – A Unique Partnership for Promoting Canada as a Destination for Clinical Trials: Part I
Minister of Health announces Acting President of the Canadian Institutes of Health Research
Innovative Medicines Canada (IMC) is pleased to provide a summary report from their conference Making Canada Better 2016, held this past November. The...
Report on the Canadian experience of Research Ethics Boards (REBs) harmonisation and centralisation CCTCC Research Ethics Board (REB) Accreditation W...
Innovative Medicines Canada, one of the CCTCC’s funding organizations, welcomes Pamela Fralick as President of the association effective today. ...
Let’s Make Canada A Go-To Destination For Clinical Trials By Dr. Chander Sehgal Let’s Make Canada A Go-To Destination For Clinical Trials ...
